Hereditary cystatin C amyloid angiopathy

Amyloid

Volumn 7, Issue 1, 2000, Pages 70-79

  Ólafsson, Ísleifur ^a   Grubb, Anders ^b  

^a Reykjavik Hospital   (Iceland)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Amyloidosis; Cerebral hemorrhage; Conformational diseases; Cystatin C

Indexed keywords

AMYLOID; CYSTATIN C;

AGING; ALLELE; ALZHEIMER DISEASE; AMYLOIDOSIS; BRAIN BLOOD VESSEL; BRAIN HEMORRHAGE; FAMILIAL DISEASE; GENEALOGY; HEREDITARY CYSTATIN C AMYLOID ANGIOPATHY; HUMAN; HUMAN TISSUE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; REVIEW; SENILE PLAQUE;

ADULT; ALLELES; CEREBRAL AMYLOID ANGIOPATHY; CEREBROSPINAL FLUID PROTEINS; CYSTATINS; FEMALE; HUMANS; MALE; MUTATION;

EID: 0034028198     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506120009146827     Document Type: Article

References (102)

1. Glenner GG and Murphey MA (1989). Amyloidosis of the nervous system. J Neurol Sci 94, 1-28
2. Vinters HV (1987). Cerebral amyloid angiopathy. A critical review. Stroke 18, 311-24
3. Haan J and Roos RAC (1990). Amyloid in central nervous system disease. Clin Neurol Neurosurg 92, 305-10
4. Haan J, Maat-Schieman MLC and Roos RAC (1994). Clinical effects of cerebral amyloid angiopathy. Dementia 5, 210-3
5. Van Broeckhoven C, Haan J, Bakker E, Hardy JA, Van Hul W, Wehnert A, Vegter-Van Der Vlis M and Roos RAC (1990). Amyloid β protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science 248, 1120-2
6. Levy E, Carman MD, Fernandez-Madrid I, Lieberburg I, Power MD, van Duinen SG, Bots GTAM, Luyendijk W and Frangione B (1990). Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248, 1124-6
7. Hendriks L, Van Duijn CM, Cras P, Cruts M, Van Hul W, Van Harskamp F, Warren A, Mclnnes MG, Anatonarakis SE, Martin JJ, Hofman A and Van Broeckhoven C (1992). Presenile dementia and cerebral hemorrhage linked to a mutation at codon 692 of beta-amyloid precursor protein gene. Nat Genet 1, 218-21
8. Kametani F, Ikeda S, Yangisawa N, Ishi T and Hanyu N (1992). Characterization of a transthyretin-related amyloid fibril protein from cerebral amyloid angiopathy type I familial amyloid polyneuropathy. J Neurol Sci 108, 178-83
9. Ghetti B, Piccardo P, Frangione B, Bugiani O, Giaccone G, Young K, Prelli F, Farlow MR, Dlouhy SR and Tagliavini F (1996). Prion protein amyloidosis. Brain Pathol 6, 127-45
10. Arnason A (1935). Apoplexie und ihre Vererbung (thesis). Acta Psychiat Neurol, suppl VII
11. Gudmundsson G, Hallgrimsson J, Jónasson TA and Bjarnason Ó (1972). Hereditary cerebral hæmorrhage with amyloidosis. Brain 95, 387-404
12. Jensson O, Thorsteinsson L, Palsdottir A, Gudmundsson G, Arnasson A, Blöndal H, Abrahamson M, Grubb A, Olafsson I and Lundwall Å (1988). An isolate of families with hereditary cystatin C amyloid angiopathy and cerebral haemorrhage in the south of Iceland. In Isobe T, Araki S, Uchino F, Kilo S and Tsubura E (eds.) Amyloid and Amyloidosis, pp. 579-84. (New York: Plenum Publishing Corp.)
13. Jensson Ó, Gudmundsson G, Árnason A, Blöndal H, Pétursdóttir I, Thorsteinsson L, Grubb A, Löfberg H, Cohen D and Frangione B (1987). Hereditary cystatin C (γ-trace) amyloid angiopathy of the CNS causing cerebral hemorrhage. Acta Neurol Scand 76, 102-14
14. Gudmundsson G, Olafsson E, Blöndal H, Arnason A and Heuser WA (1998). Hereditary cerebral hemorrhage in Iceland. Incidence for the 35 year period 1960-1994. Icelandic Med J suppl 37, 76
15. Graffagnino C, Herbstreith MH, Schmechel DE, Levy E, Roses AD and Alberts MJ (1995). Cystatin C mutation in an elderly man with sporadic amyloid angiopathy and intracerebral hemorrhage. Stroke 25, 2190-3
16. McCarron MO, Nicoll JAR, Stewart J, Ironside JW, Mann DMA, Love S, Graham DI and Grubb A (1999). Cystatin C mutation in sporadic cerebral amyloid angiopathy-related hemorrhage. Neurology, in press
17. Sveinbjörnsdottir S, Blöndal H, Gudmundsson G, Kjartansson O, Jonsdottir S and Gudmundsson G (1996). Progressive dementia and leucoencephalopathy as the initial presentation of late onset hereditary cystatin-C amyloidosis. Clinicopathological presentation of two cases. J Neurol Sci 140, 101-8
18. Löfberg H, Grubb AO, Nilsson EK, Jensson Ó, Gudmundsson G, Blöndal H, Árnason A and Thorsteinsson L (1987). Immunohistochemical characterization of the amyloid deposits and quantitation of pertinent cerebrospinal proteins in hereditary cerebral hemorrhage with amyloidosis. Stroke 18, 431-40
19. Thorsteinsson L, Blöndal H, Jensson Ó and Gudmundsson G (1988). Distribution of cystatin C amyloid deposits in the Icelandic patients with hereditary cystatin C amyloid angiopathy. In Isobe T, Araki S, Uchino F, Kito S and Tsubura E (eds.) Amyloid and Amyloidosis, pp. 585-90. (New York: Plenum Publishing Corp.)
20. Wang ZZ, Jensson O, Thorsteinsson L and Vinters HV (1997). Microvascular degeneration in hereditary cystatin C amyloid angiopathy of the brain. APMIS 105, 41-7
21. Benedikz E, Blöndal H and Gudmundsson G (1990). Skin deposits in hereditary cystatin C amyloidosis. Virchows Archiv A 417, 325-31
22. Jensson O, Gudmundsson G, Arnason A, Blöndal H, Grubb A and Löfberg H (1986). Hereditary central nervous system γ-trace amyloid angiopathy and stroke in Icelandic families. In Glenner GG, Ossserman EF, Benditt EP, Calkins E, Cohen AS and Zucker-Franklin D (eds.) Amyloidosis, pp. 585-90 (New York, Plenum Publishing Corp.)
23. Rowe IF, Jensson O, Lewis PD, Candy J, Tennent GA and Pepys MB (1984). Immunohistochemical demonstration of amyloid P component in cerebrovascular amyloidosis. Neuropathol Appl Neurobiol 10, 53-61
24. Maruyama K, Ikeda S, Ishihara T, Allsop D and Yanagiswa N (1990). Immunohistochemical characterization of cerebrovascular amyloid in 46 autopsied cases using antibodies to β protein and cystatin C. Stroke 21, 397-403
25. Haan J, Maat-Schieman MLC, Van Duinen SG, Jensson Ó, Thorsteinsson L and Roos RAC (1994). Colocalization of A4 and cystatin C in cortical blood vessels in Dutch but not in Icelandic hereditary cerebral angiopathy with amyloidosis. Acta Neurol Scand 89, 367-71
26. Shimode K, Kobayashi S, Imoka K, Umage N and Nagai A (1996). Leukoencephalopathy-related cerebral amyloid angiopathy with cystatin C deposition. Stroke 27, 1417-9
27. Vinters HV, Secor DL, Pardridge WM and Gray F (1990). Immunohistochemical study of cerebral amyloid angiopathy. III. Widespread Alzheimer A4 peptide in cerebral microvessel walls colocalizes with gamma trace in patients with leukoencephalopathy. Ann Neurol 28, 34-42
28. Anders KH, Wang ZZ, Kornfeld M, Gray F, Soontornniyomkij V, Reed LA, Hart MM, Menchine M, Secor DL and Vinters HV (1997). Giant cell arteritis in association with cerebral amyloid angiopathy: immunohistochemical and molecular studies. Hum Pathol 28, 1237-46
29. Maruyama K, Kametani F, Ikeda S, Ishihara T and Yanagisawa N (1992). Characterization of amyloid protein from a case of cerebral amyloid angiopathy showing immunohistochemical reactivity for both β protein and cystatin C. Neurosci Lett 144, 38-12
30. Cohen DH, Feiner H, Jensson Ó and Frangione B (1983). Amyloid fibril in hereditary cerebral hemorrhage with amyloidosis (HCHWA) is related to the gastroentero-pancreatic neuroendocrine protein, gamma trace. J Exp Med 158, 623-8
31. Grubb A and Löfberg H (1982). Human γ-trace, a basic microprotein: Amino acid sequence and presence in the adenohypophysis. Proc Natl Acad Sci USA 79, 3024-7
32. Abrahamson M, Grubb A, Ólafsson Í and Lundwall Å (1987). Molecular cloning and sequence analysis of a cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin C. FEBS Lett 216, 229-33
33. Turk V, Brzin J, Longer M, Ritonja A and Eropkin M (1983). Protein inhibitors of cysteine proteinases III. Amino acid sequence of cystatin from chicken egg white. Hoppe-Seyler's Z Physiol Chem 364, 1487-96
34. Schwabe C, Anastasi A, Crow H, McDonald JK and Barrett A (1984). Cystatin: Amino acid sequence and possible secondary structure. Biochem J 217, 813-7
35. Bode W, Engh R, Musil D, Thiele U, Huber R, Karashikov A, Brzin J, Kos J and Turk V (1988). The 2.0 Å X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO 7, 2593-9
36. Dieckmann T, Mitschang L, Hofmann M, Kos J, Turk V, Auerswald EA, Jaenicke R and Oschkinat H (1993). The structures of native chicken cystatin and of a recombinant unphosphorylated variant in solution. J Mol Biol 234, 1048-59
37. Ekiel I, Abrahamson M, Fulton DB, Lindahl P, Storer AC, Levadoux W, Lafrance M, Labelle S, Pomerleau Y, Groleau D, LeSauteur L and Gehring K (1997). NMR structural studies of human cystatin C dimers and monomers. J Mol Biol 271, 266-77
38. Abrahamson M, Barrett AJ, Salvesen G and Grubb A (1986). Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. J Biol Chem 261, 11281-9
39. Abrahamson M, Ritonja A, Brown MA, Grubb A, Machleidt W and Barrett AJ (1987). Identification of the probable inhibitory reactive sites of the cysteine proteinase inhibitors human cystatin C and chicken cystatin. J Biol Chem 262, 9688-94
40. Hall A, Håkansson K, Mason RW, Grubb A and Abrahamson M (1995). Structural basis for the biological specificity of cystatin C. Identification of leucine 9 in the N-terminal binding region as a selectivity-conferring residue in the inhibition of mammalian cysteine peptidases. J Biol Chem 270, 5115-21
41. Hall A, Ekiel I, Mason RW, Kasprzykowski F, Grubb A and Abrahamson M (1998). Structural basis for different inhibitory specificities of human cystatins C and D. Biochemistry 37, 4071-9
42. Hall A, Dalboge H, Grubb A and Abrahamson M (1993). Importance of the evolutionarily conserved glycine residue in the N-terminal region of human cystatin C (Gly-11) for cysteine endopeptidase inhibition. Biochem J 291, 123-9
43. Björk I, Brieditis I, Raub-Segall E, Pol E, Håkansson K and Abrahamson M (1996). The importance of the second hairpin loop of cystatin C for proteinase binding. Characterization of the interaction of Tip-106 variants of the inhibitor with cysteine proteinases. Biochemistry 35, 10720-6
44. Mason RW, Sol-Church K and Abrahamson M (1998). Amino acid substitutions in the N-terminal segment of cystatin C create selective protein inhibitors of lysosomal cysteine proteinases. Biochem J 330, 833-8
45. Lindahl P, Ripoll D, Abrahamson M, Mort JS and Storer AC (1994). Evidence for the interaction of valine-10 in cystatin C with the S2 subsite of cathepsin B. Biochemistry 33, 4384-9
46. Grubb A, Abrahamson M, Olafsson I, Trojnar J, Kasprzykowska R, Kasprzykowski F and Grzonka Z (1990). Synthesis of cysteine proteinase inhibitors structurally based on the proteinase interacting N-terminal region of human cystatin C. Biol Chem Hoppe Seyler 371 Suppl, 137-44
47. Hall A, Abrahamson M, Grubb A, Trojnar J, Kania P, Kasprzykowska R and Kasprzykowski F (1992). Cystatin C based peptidyl diazomethanes as cysteine proteinase inhibitors: influence of the peptidyl chain length. J Enzyme Inhib 6, 113-23
48. Björck L, Åkesson P, Bonus M, Trojnar J, Abrahamson M, Olafsson I and Grubb A (1989). Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor. Nature 337, 385-6
49. Björck L, Grubb A and Kjellen L (1990). Cystatin C, a human proteinase inhibitor, blocks replication of herpes simplex virus. J Virol 64, 941-3
50. Chen JM, Dando PM, Rawlings ND, Brown MA, Young NE, Stevens RA, Hewitt E, Watts C and Bairett AJ (1997). Cloning, isolation and characterization of mammalian legumain, an asparaginyl endopeptidase. J Biol Chemistry 272, 8090-8
51. Alvarez-Fernandez M, Barrett AJ, Gerhartz B Dando PM, Ni J and Abrahamson M (1999). Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site. J Biol Chem 274, 19195-203
52. Barrett AJ, Davies ME and Grubb A (1984). The place of human γ-trace (cystatin C) amongst the cysteine proteinase inhibitors. Biochcm Biophys Res Commun 120, 631-6
53. Rawlings ND and Barrett AJ (1990). Evolution of proteins of the cystatin superfamily. J Mol Evol 30, 60-71
54. Freije JP, Abrahamson M, Olafsson I, Velasco G, Grubb A and Lopez-Otin C (1991). Structure and expression of the gene encoding cystatin D, a novel human cysteine proteinase inhibitor. J Biol Chem 266, 20538-43
55. Sotiropoulou G, Anisowicz A and Sager R (1997). Identification, cloning, and characterization of cystatin M, a novel cysteine proteinase inhibitor, down-regulated in breast cancer. J Biol Chem 272, 903-10
56. Ni J, Abrahamson, Zhang M, Fernandez MA, Grubb A, Su J, Yu G-L, Li Y, Parmelee D, Xing L, Coleman TA, Gentz S, Thotakura R, Nguyen N, Hesselberg M and Gentz R (1997). Cystatin E is a novel human cysteine proteinase inhibitor with structural resemblance to family 2 cystatins. J Biol Chem 272, 10853-8
57. Ni J, Fernandez MA, Danielsson L, Chillakuru RA, Zhang J, Grubb A, Su J, Gentz R and Abrahamson M (1998). Cystatin F is a glycosylated human low molecular weight cysteine proteinase inhibitor. J Biol Chem 273, 24797-804
58. 2-thiol proteinase inhibitor and its identity with low molecular weight kininogen. Biochemistry 23, 5691-7
59. Müller-Esterl W, Fritz H, Machleidt W, Ritonja A, Brzin J, Kotnik M, Turk V, Kellerman J and Lottspeich F (1985). Human plasma kininogens are identical with α-cysteine proteinase inhibitors. Evidence from immunological, enzymological and sequence data. FEBS Lett 182, 310-4
60. Barrett AJ (1987). The cystatins: a new class of peptidase inhibitors. Trends Biochem Sci 12, 193-6
61. Abrahamson M, Islam MQ, Szpirer J, Szpirer C and Levan G (1989). The human cystatin C gene (CST3) mutated in hereditary cystatin C amyloid angiopathy, is located on chromosome 20. Hum Genet 82, 223-6
62. Schnittger S, Gopal Rao VVN, Abrahamson M and Hansmann I (1993). Cystatin C (CST3), the candidate gene for hereditary cystatin C amyloid angiopathy (HCCAA), and other members of the cystatin gene family are clustered on chromosome 20p11.2. Genomics 16, 50-5
63. Abrahamson M, Ólafsson Í, Pálsdóttir Á, Ulvsbäck M, Lundwall Å, Jensson Ó and Grubb A (1990). Structure and expression of the human cystatin C gene. Biochem J 268, 287-94
64. Ólafsson Í (1995). The human cystatin C gene promoter: functional analysis and identification of heterogenous mRNA. Scand J Clin Lab Invest 55, 597-609
65. Emilsson V, Thorsteinsson L, Jensson Ó and Gudmundsson G (1996). Human cystatin C gene expression and regulation by TGFβ1: Implications for the pathogenesis of hereditary cystatin C amyloid angiopathy causing brain hemorrhage. Amyloid: Int J Exp Clin Invest 3, 110-8
66. Solem M, Rawson C, Lindburg K and Barnes D (1990). Transforming growth factor beta regulates cystatin C in serum free mouse embryo (SFME) cells. Biochem Biophys Res Commun 172, 945-51
67. Bjarnadóttir M, Grubb A and Ólafsson Í (1995). Promoter-mediated, dexamethasone-induced increase in cystatin C production by HeLa cells. Scand J Clin Lab Invest 55, 617-23
68. Warfei AH, Zucker-Franklin D, Frangione B and Ghiso J (1987). Constitutive secretion of cystatin C (γ-trace) by monocytes and macrophages and its downregulation after stimulation. J Exp Med 166, 1912-7
69. Warfel AH, Cardozo C, Yoo OH and Zucker-Franklin D (1991). Cystatin C and cathepsin B production by alveolar macrophages from smokers and nonsmokers. J Leukocyte Biol 49, 41-7
70. Chapman HA, Reilly JJ, Yee R and Grubb A (1990). Identification of cystatin C, a cysteine proteinase inhibitor, as a major secretory product of human alveolar macrophages in vitro. Am Rev Respir Dis 141, 698-705
71. Grubb A, Simonsen O, Sturfelt G, Truedsson L and Thysell H (1985). Serum concentration of cystatin C, factor D and β2-microglobulin as a measure of glomerular filtration rate. Acta Med Scand 218, 499-503
72. Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindström V and Grubb A (1994). Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 40, 1921-6
73. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, Price CP (1995) Serum cystatin C measured by automated immunoassay : A more sensitive marker of changes in GFR than serum creatinine. Kidney Internat 47, 312-8.
74. Grubb A, Jensson Ó, Gudmundsson G, Árnason A, Löfberg H and Malm J (1984). Abnormal metabolism of γ-trace alka-line microprotein: The basic defect in hereditary cerebral hemorrhage with amyloidosis. New Engl J Med 311, 1547-9
75. Ólafsson Í, Gudmundsson G, Abrahamson M, Jensson Ó and Grubb A (1990). The amino terminal portion of cerebrospinal fluid cystatin C in hereditary cystatin C amyloid angiopathy is not truncated: direct sequence analysis from agarose gel electropherograms. Scand J Clin Lab Invest 50, 85-93
76. Ghiso J, Jensson Ó and Frangione B (1986). Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of γ-trace basic protein (cystatin C). Proc Natl Acad Sci USA 83, 2974-8
77. Pálsdóttir Á, Abrahamson M, Thorsteinsson L, Árnason A, Ólafsson Í, Grubb A and Jensson Ó (1988). Mutation in cystatin C gene causes hereditary brain haemorrhage. Lancet ii, 603-4
78. Abrahamson M, Jónsdóttir S, Ólafsson Í, Jensson Ó and Grubb A (1992). Hereditary cystatin C amyloid angiopathy: Identification of the disease-causing mutation and specific diagnosis by polymerase chain reaction based analysis. Hum Genet 89, 377-80
79. Levy E, Lopez-Otin C, Ghiso J, Geltner D and Frangione B (1989). Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteinases. J Exp Med 169, 1771-8
80. Abrahamson M, Dalböge H, Olafsson I, Carlsen S and Grubb A (1988). Efficient production of native biologically active human cystatin C in Escherichia coll. FEBS Lett 236, 14-8
81. Dalboge H, Jensen EB, Tottrup H, Grubb A, Abrahamson M Olafsson I and Carlsen S (1989). High-level expression of active human cystatin C in Escherichia coli. Gene 79, 325-32
82. Abrahamson M and Grubb A (1994). Increased body temperature accelerates aggregation of (Leu-68->Gln)cystatin C, the amyloid forming protein in hereditary cystatin C amyloid angiopathy. Proc Natl Acad Sci USA 91, 1416-20
83. Gerhartz B, Ekiel I and Abrahamson M (1998). Two stable unfolding intermediates of the disease-causing L68Q variant of human cystatin C. Biochemistry 37, 17309-17
84. Ekiel I and Abrahamson M (1996). Folding-related dimerization of human cystatin C. J Biol Chem 271, 1314-21
85. Merz GS, Benedikz E, Schwenk V, Johansen TE, Vogel LK, Rushbrook JI and Wisniewski HM (1997). Human cystatin C forms an inactive dimer during intracellular trafficking in transfected CHO cells. J Cell Physiol 173, 423-32
86. Bjarnadottir M, Wulff BS, Sameni M, Sloane BF, Keppler D, Grubb A and Abrahamson M (1998). Intracellular accumulation of the amyloidogenic L68Q variant of human cystatin C in NIH/3T3 cells. Mol Pathol 51, 317-26
87. Benedikz E, Merz GS, Schwenk V, Johansen TE, Wisniewski HM and Rushbrook JI (1999). Cellular processing of the amyloidogenic cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type. Amyloid: Int J Exp Clin Invest 6, 172-82
88. Wei L, Berman Y, Castano EM, Cadene M, Beavis RC, Devi L and Levy E (1998). Instability of the amyloidogenic cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type. J Biol Chem 273, 11806-14
89. Thorsteinsson L, Georgsson G, Ásgeirsson B, Bjarnadóttir M, Olafsson Í, Jensson Ó and Gudmundsson G (1992). On the role of monocytes/macrophages in the pathogenesis of central nervous system lesion in hereditary cystatin C amyloid angiopathy. J Neurol Sci 108, 121-8
90. Perutz MF (1997). Mutations make enzyme polymerize. Nature 385, 773-5
91. Fink AL (1999). Chaperone-mediated protein folding. Physiol Rev 79, 425-49
92. Booth DR, Sunde M, Bellotti V, Robinson CV, Hutchinson WL, Fraser PE, Hawkins PN, Dobson CM, Radford SE, Blake CCF and Pepys MB (1997). Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 385, 787-93
93. Bellotti V, Mangione P and Stoppini M (1999). Biological activity and pathological implications of misfolded proteins. Cell Mol Life Sci 55, 977-91
94. Wisniewski T, Aucoururier P, Soto C and Frangione B (1998). The prionoses and other conformational disorders. Amyloid: Int J Exp Clin Invest 5, 212-24
95. Aridor M and Balch WE (1999). Integration of endoplasmic reticulum signaling in health and disease. Nat Med 5, 745-51
96. Carell RW and Lomas DA (1997). Conformational disease. Lancet 350, 134-8
97. Shi GP, Sukhova GK, Grubb A, Ducharme A, Rhode LH, Lee RT, Ridker PM, Libby P and Chapman HA (1999). Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 104, 1191-7
98. 1-antitrypsin accumulation in the liver. Nature 357, 605-7
99. Findeis MA, Musso GM, Arico-Muendel C, Benjamin HW, Hundal AM, Lee J J, Chin J, Kelley M, Wakefield J, Hayward NJ and Molineaux SM (1999). Modified-peptide inhibitors of amyloid beta-peptide polymerization. Biochemistry 38, 6791-800
100. Soto C, Sigurdsson EM, Morelli L, Kumar RA, Castano EM and Frangione B (1998). Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat Med 4, 822-6
101. Cummings C J, Manchini MA, Antalffy B, DeFranco DB, Orr HT and Zoghbi HY (1998). Chaperone suppression of aggregation and altered proteasome localization imply misfolding in SCA1. Nat Genet 19, 148-54
102. Loo TW and Clarke DM (1997). Correction of defective protein kinesis of human P-glycoprotein mutants by substrates and modulators. J Biol Chem 272, 709-12